Eureka Forbes Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 26, 2025, 11:19 pm

Market Cap	9,670 Cr.
Current Price	500
High / Low	648/397
Stock P/E	67.8
Book Value	222
Dividend Yield	0.00 %
ROCE	3.46 %
ROE	2.45 %
Face Value	10.0
PEG Ratio	1.09

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Eureka Forbes Ltd

Competitors of Eureka Forbes Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
MPL Plastics Ltd	12.5 Cr.	10.0	18.9/8.50	1.40	2.59	0.00 %	%	%	10.0
Hawkins Cookers Ltd	4,185 Cr.	7,910	9,200/6,152	36.6	622	1.52 %	44.5 %	36.0 %	10.0
Harsha Engineers International Ltd	3,517 Cr.	386	614/330	25.1	143	0.26 %	13.4 %	10.6 %	10.0
Gorani Industries Ltd	43.4 Cr.	81.0	123/76.3	39.5	23.5	0.00 %	12.2 %	11.5 %	10.0
Eureka Forbes Ltd	9,670 Cr.	500	648/397	67.8	222	0.00 %	3.46 %	2.45 %	10.0
Industry Average	9,247.82 Cr	1,446.15		56.13	175.51	0.40%	14.48%	11.33%	6.69

All Competitor Stocks of Eureka Forbes Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	3	373	525	575	472	508	505	592	539	553	553	673	598
Expenses	5	354	482	575	431	461	459	541	496	500	498	601	539
Operating Profit	-2	20	43	0	41	47	46	51	42	53	55	72	59
OPM %	-49%	5%	8%	0%	9%	9%	9%	9%	8%	10%	10%	11%	10%
Other Income	0	2	1	-15	-10	-5	2	2	3	-13	2	6	4
Interest	0	4	6	6	4	3	3	3	2	2	2	2	1
Depreciation	0	9	13	16	13	13	13	13	13	14	14	14	15
Profit before tax	-2	9	24	-36	13	26	31	37	30	24	42	62	47
Tax %	6%	45%	27%	-26%	25%	37%	29%	31%	25%	12%	25%	25%	26%
Net Profit	-2	5	18	-27	10	16	22	25	23	21	31	47	35
EPS in Rs	-3.77	0.25	0.92	-1.39	0.51	0.84	1.14	1.32	1.17	1.11	1.61	2.41	1.80

Last Updated: March 4, 2025, 12:22 pm

Below is a detailed analysis of the quarterly data for Eureka Forbes Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 598.00 Cr.. The value appears to be declining and may need further review. It has decreased from 673.00 Cr. (Sep 2024) to 598.00 Cr., marking a decrease of 75.00 Cr..
For Expenses, as of Dec 2024, the value is 539.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 601.00 Cr. (Sep 2024) to 539.00 Cr., marking a decrease of 62.00 Cr..
For Operating Profit, as of Dec 2024, the value is 59.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Sep 2024) to 59.00 Cr., marking a decrease of 13.00 Cr..
For OPM %, as of Dec 2024, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Sep 2024) to 10.00%, marking a decrease of 1.00%.
For Other Income, as of Dec 2024, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Sep 2024) to 4.00 Cr., marking a decrease of 2.00 Cr..
For Interest, as of Dec 2024, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Sep 2024) to 15.00 Cr., marking an increase of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Sep 2024) to 47.00 Cr., marking a decrease of 15.00 Cr..
For Tax %, as of Dec 2024, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2024) to 26.00%, marking an increase of 1.00%.
For Net Profit, as of Dec 2024, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Sep 2024) to 35.00 Cr., marking a decrease of 12.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 1.80. The value appears to be declining and may need further review. It has decreased from 2.41 (Sep 2024) to 1.80, marking a decrease of 0.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 1:11 pm

Metric	Mar 2012	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	0	0	28	33	27	26	16	8	381	2,080	2,189	2,377
Expenses	0	0	28	32	27	26	16	9	363	1,949	1,997	2,139
Operating Profit	0	0	1	2	-1	-0	-0	-1	18	132	192	238
OPM %			2%	5%	-3%	-1%	-0%	-17%	5%	6%	9%	10%
Other Income	0	0	0	-0	0	0	0	0	2	-30	-7	-0
Interest	0	0	0	1	0	0	0	0	4	20	10	6
Depreciation	0	0	0	0	0	0	0	0	9	55	53	56
Profit before tax	0	0	0	1	-1	-1	-1	-2	7	27	122	175
Tax %			-8%	8%	9%	-9%	56%	1%	59%	37%	25%
Net Profit	0	0	0	1	-1	-1	-1	-2	3	17	92	134
EPS in Rs	0.00	0.00	0.50	2.62	-4.70	-2.48	-1.84	-3.38	0.14	0.88	4.73	6.93
Dividend Payout %			0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-200.00%	0.00%	0.00%	-100.00%	250.00%	466.67%	441.18%
Change in YoY Net Profit Growth (%)	0.00%	200.00%	0.00%	-100.00%	350.00%	216.67%	-25.49%

Eureka Forbes Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	143%
3 Years:	553%
TTM:	11%

Compounded Profit Growth
10 Years:	%
5 Years:	171%
3 Years:	300%
TTM:	55%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	13%
1 Year:	-2%

Return on Equity
10 Years:	%
5 Years:	1%
3 Years:	1%
Last Year:	2%

Last Updated: Unknown

Balance Sheet

Last Updated: March 14, 2025, 1:48 pm

Month	Mar 2012	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	0.05	0.05	3	3	3	3	5	5	193	193	193	193
Reserves	-0	-0	-1	-0	-2	-2	-3	-5	3,874	3,886	4,010	4,100
Borrowings	0	0	4	4	4	4	2	2	253	139	39	79
Other Liabilities	0	0	12	12	9	9	7	5	1,815	1,810	1,878	1,986
Total Liabilities	0	0	18	18	14	14	10	7	6,135	6,029	6,120	6,359
Fixed Assets	0	0	1	0	0	0	0	0	5,498	5,475	5,457	5,469
CWIP	0	0	0	0	0	0	0	0	0	2	1	0
Investments	0	0	0	0	0	0	0	0	87	101	80	82
Other Assets	0	0	17	18	14	14	10	7	550	451	582	808
Total Assets	0	0	18	18	14	14	10	7	6,135	6,029	6,120	6,359

Below is a detailed analysis of the balance sheet data for Eureka Forbes Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹193.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 193.00 Cr..
For Reserves, as of Sep 2024, the value is ₹4,100.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,010.00 Cr. (Mar 2024) to ₹4,100.00 Cr., marking an increase of 90.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹79.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 39.00 Cr. (Mar 2024) to ₹79.00 Cr., marking an increase of 40.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹1,986.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,878.00 Cr. (Mar 2024) to ₹1,986.00 Cr., marking an increase of 108.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹6,359.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,120.00 Cr. (Mar 2024) to ₹6,359.00 Cr., marking an increase of 239.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹5,469.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,457.00 Cr. (Mar 2024) to ₹5,469.00 Cr., marking an increase of 12.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 1.00 Cr..
For Investments, as of Sep 2024, the value is ₹82.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Mar 2024) to ₹82.00 Cr., marking an increase of 2.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹808.00 Cr.. The value appears strong and on an upward trend. It has increased from 582.00 Cr. (Mar 2024) to ₹808.00 Cr., marking an increase of 226.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹6,359.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,120.00 Cr. (Mar 2024) to ₹6,359.00 Cr., marking an increase of 239.00 Cr..

Notably, the Reserves (4,100.00 Cr.) exceed the Borrowings (79.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	1	0	37	171	195
Cash from Investing Activity +	0	0	7	-22	-35
Cash from Financing Activity +	-1	-0	-31	-150	-117
Net Cash Flow	-1	-0	13	-1	43

Free Cash Flow

Month	Mar 2012	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	0.00	0.00	-3.00	-2.00	-5.00	-4.00	-2.00	-3.00	-235.00	-7.00	153.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days		156	141	107	110	63	110	147	22	23
Inventory Days		34	21	37	33	90	109	638	91	99
Days Payable		164	153	137	143	159	256	549	99	89
Cash Conversion Cycle		26	10	7	1	-7	-37	235	14	33
Working Capital Days		37	34	31	15	1	-35	-357	-84	-82
ROCE %	0%		24%	-12%	-5%	-4%	-58%	0%	2%	3%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	73.85%	73.33%	73.23%	73.23%	72.56%	72.56%	72.56%	72.56%	62.56%	62.56%	62.56%	62.56%
FIIs	11.53%	11.50%	11.55%	11.54%	10.94%	10.76%	10.61%	10.76%	16.01%	13.21%	12.62%	12.56%
DIIs	0.68%	0.79%	1.22%	1.48%	1.87%	2.73%	3.45%	4.00%	5.64%	6.30%	6.67%	6.60%
Government	0.86%	0.86%	0.86%	0.86%	0.86%	0.86%	0.86%	0.86%	0.86%	0.86%	0.86%	0.86%
Public	13.08%	13.52%	13.15%	12.90%	13.79%	13.10%	12.53%	11.83%	14.93%	17.08%	17.29%	17.41%
No. of Shareholders	13,345	13,727	14,761	14,369	14,118	14,836	15,838	21,843	26,751	28,115	31,628	32,453

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Tata Small Cap Fund	1,121,339	0.69	54.08	1,121,339	2025-04-22 17:25:12	0%
DSP Tiger Fund	842,641	0.83	40.64	842,641	2025-04-22 17:25:12	0%
Bandhan Small Cap Fund	693,139	0.57	33.43	693,139	2025-04-22 17:25:12	0%
PGIM India Small Cap Fund	527,250	1.69	25.43	527,250	2025-04-22 17:25:12	0%
Union Flexi Cap Fund	382,396	0.84	18.44	382,396	2025-04-22 17:25:12	0%
Union Small Cap Fund	372,980	1.17	17.99	372,980	2025-04-22 17:25:12	0%
Axis Innovation Fund	277,234	1.05	13.37	277,234	2025-04-22 17:25:12	0%
Sundaram Consumption Fund	257,002	0.83	12.39	257,002	2025-04-22 17:25:12	0%
DSP Equity Savings Fund	157,244	0.56	7.58	157,244	2025-04-22 17:25:12	0%
Union ELSS Tax Saver Fund	157,200	0.81	7.58	157,200	2025-04-22 17:25:12	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	4.94	1.37	0.72	-3.38
Diluted EPS (Rs.)	4.93	1.37	0.72	-3.38
Cash EPS (Rs.)	7.74	4.29	0.60	-3.08
Book Value[Excl.RevalReserv]/Share (Rs.)	218.47	211.85	210.74	0.28
Book Value[Incl.RevalReserv]/Share (Rs.)	218.47	211.85	210.74	0.28
Revenue From Operations / Share (Rs.)	113.15	107.74	19.73	16.25
PBDIT / Share (Rs.)	10.72	8.02	1.07	-2.65
PBIT / Share (Rs.)	7.93	5.11	0.59	-2.95
PBT / Share (Rs.)	6.64	1.99	0.36	-3.36
Net Profit / Share (Rs.)	4.94	1.37	0.13	-3.38
NP After MI And SOA / Share (Rs.)	4.94	1.37	0.13	-3.38
PBDIT Margin (%)	9.47	7.44	5.41	-16.34
PBIT Margin (%)	7.00	4.73	3.00	-18.14
PBT Margin (%)	5.86	1.84	1.84	-20.67
Net Profit Margin (%)	4.36	1.26	0.68	-20.77
NP After MI And SOA Margin (%)	4.36	1.27	0.68	-20.77
Return on Networth / Equity (%)	2.26	0.64	0.06	-1175.41
Return on Capital Employeed (%)	2.96	1.94	0.22	-886.48
Return On Assets (%)	1.56	0.44	0.04	-22.82
Long Term Debt / Equity (X)	0.00	0.01	0.01	0.00
Total Debt / Equity (X)	0.01	0.02	0.05	10.81
Asset Turnover Ratio (%)	0.36	0.34	0.12	0.00
Current Ratio (X)	0.63	0.52	0.54	0.75
Quick Ratio (X)	0.37	0.28	0.26	0.46
Inventory Turnover Ratio (X)	3.47	2.57	0.73	0.00
Interest Coverage Ratio (X)	21.22	7.66	4.67	-6.45
Interest Coverage Ratio (Post Tax) (X)	12.34	4.28	1.59	-7.20
Enterprise Value (Cr.)	8769.60	8356.88	7796.16	0.00
EV / Net Operating Revenue (X)	4.01	4.01	20.42	0.00
EV / EBITDA (X)	42.28	53.83	377.28	0.00
MarketCap / Net Operating Revenue (X)	4.04	3.96	19.83	0.00
Price / BV (X)	2.09	2.01	1.86	0.00
Price / Net Operating Revenue (X)	4.04	3.96	19.83	0.00
EarningsYield	0.01	0.00	0.00	0.00

After reviewing the key financial ratios for Eureka Forbes Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 4.94. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 23) to 4.94, marking an increase of 3.57.
For Diluted EPS (Rs.), as of Mar 24, the value is 4.93. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 23) to 4.93, marking an increase of 3.56.
For Cash EPS (Rs.), as of Mar 24, the value is 7.74. This value is within the healthy range. It has increased from 4.29 (Mar 23) to 7.74, marking an increase of 3.45.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 218.47. It has increased from 211.85 (Mar 23) to 218.47, marking an increase of 6.62.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 218.47. It has increased from 211.85 (Mar 23) to 218.47, marking an increase of 6.62.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 113.15. It has increased from 107.74 (Mar 23) to 113.15, marking an increase of 5.41.
For PBDIT / Share (Rs.), as of Mar 24, the value is 10.72. This value is within the healthy range. It has increased from 8.02 (Mar 23) to 10.72, marking an increase of 2.70.
For PBIT / Share (Rs.), as of Mar 24, the value is 7.93. This value is within the healthy range. It has increased from 5.11 (Mar 23) to 7.93, marking an increase of 2.82.
For PBT / Share (Rs.), as of Mar 24, the value is 6.64. This value is within the healthy range. It has increased from 1.99 (Mar 23) to 6.64, marking an increase of 4.65.
For Net Profit / Share (Rs.), as of Mar 24, the value is 4.94. This value is within the healthy range. It has increased from 1.37 (Mar 23) to 4.94, marking an increase of 3.57.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 4.94. This value is within the healthy range. It has increased from 1.37 (Mar 23) to 4.94, marking an increase of 3.57.
For PBDIT Margin (%), as of Mar 24, the value is 9.47. This value is below the healthy minimum of 10. It has increased from 7.44 (Mar 23) to 9.47, marking an increase of 2.03.
For PBIT Margin (%), as of Mar 24, the value is 7.00. This value is below the healthy minimum of 10. It has increased from 4.73 (Mar 23) to 7.00, marking an increase of 2.27.
For PBT Margin (%), as of Mar 24, the value is 5.86. This value is below the healthy minimum of 10. It has increased from 1.84 (Mar 23) to 5.86, marking an increase of 4.02.
For Net Profit Margin (%), as of Mar 24, the value is 4.36. This value is below the healthy minimum of 5. It has increased from 1.26 (Mar 23) to 4.36, marking an increase of 3.10.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.36. This value is below the healthy minimum of 8. It has increased from 1.27 (Mar 23) to 4.36, marking an increase of 3.09.
For Return on Networth / Equity (%), as of Mar 24, the value is 2.26. This value is below the healthy minimum of 15. It has increased from 0.64 (Mar 23) to 2.26, marking an increase of 1.62.
For Return on Capital Employeed (%), as of Mar 24, the value is 2.96. This value is below the healthy minimum of 10. It has increased from 1.94 (Mar 23) to 2.96, marking an increase of 1.02.
For Return On Assets (%), as of Mar 24, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.44 (Mar 23) to 1.56, marking an increase of 1.12.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.36. It has increased from 0.34 (Mar 23) to 0.36, marking an increase of 0.02.
For Current Ratio (X), as of Mar 24, the value is 0.63. This value is below the healthy minimum of 1.5. It has increased from 0.52 (Mar 23) to 0.63, marking an increase of 0.11.
For Quick Ratio (X), as of Mar 24, the value is 0.37. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 23) to 0.37, marking an increase of 0.09.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.47. This value is below the healthy minimum of 4. It has increased from 2.57 (Mar 23) to 3.47, marking an increase of 0.90.
For Interest Coverage Ratio (X), as of Mar 24, the value is 21.22. This value is within the healthy range. It has increased from 7.66 (Mar 23) to 21.22, marking an increase of 13.56.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 12.34. This value is within the healthy range. It has increased from 4.28 (Mar 23) to 12.34, marking an increase of 8.06.
For Enterprise Value (Cr.), as of Mar 24, the value is 8,769.60. It has increased from 8,356.88 (Mar 23) to 8,769.60, marking an increase of 412.72.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.01. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 23) which recorded 4.01.
For EV / EBITDA (X), as of Mar 24, the value is 42.28. This value exceeds the healthy maximum of 15. It has decreased from 53.83 (Mar 23) to 42.28, marking a decrease of 11.55.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.04. This value exceeds the healthy maximum of 3. It has increased from 3.96 (Mar 23) to 4.04, marking an increase of 0.08.
For Price / BV (X), as of Mar 24, the value is 2.09. This value is within the healthy range. It has increased from 2.01 (Mar 23) to 2.09, marking an increase of 0.08.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.04. This value exceeds the healthy maximum of 3. It has increased from 3.96 (Mar 23) to 4.04, marking an increase of 0.08.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Eureka Forbes Ltd as of April 27, 2025 is: 300.91

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 27, 2025, Eureka Forbes Ltd is Overvalued by 39.82% compared to the current share price 500.00

Intrinsic Value of Eureka Forbes Ltd as of April 27, 2025 is: 488.80

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 27, 2025, Eureka Forbes Ltd is Overvalued by 2.24% compared to the current share price 500.00

Last 5 Year EPS CAGR: 62.44%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -40.00, which is a positive sign. The company has higher reserves (1,321.42 cr) compared to borrowings (44.17 cr), indicating strong financial stability. The company has shown consistent growth in sales (43.75 cr) and profit (27.25 cr) over the years.	The stock has a low average ROCE of -4.55%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 25.64, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Eureka Forbes Ltd:
1. Net Profit Margin: 4.36%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 2.96% (Industry Average ROCE: 13.37%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 2.26% (Industry Average ROE: 10.46%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 12.34
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.37
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 67.8 (Industry average Stock P/E: 56.13)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.01
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Eureka Forbes Ltd. is a Public Limited Listed company incorporated on 26/11/2008 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L27310MH2008PLC188478 and registration number is 188478. Currently Company is involved in the business activities of Manufacture of filtering and purifying machinery or apparatus for liquids and gases. Company's Total Operating Revenue is Rs. 2189.23 Cr. and Equity Capital is Rs. 193.48 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Domestic Appliances	B1/B2, 7th Floor, 701, Marathon Innova, Mumbai Maharashtra 400013	compliance@eurekaforbes.com http://www.eurekaforbes.com

Management
Name	Position Held
Mr. Arvind Uppal	Chairman, Non Ind & Non Exe Director
Mr. Pratik Rashmikant Pota	Managing Director & CEO
Mr. Sahil Dilip Dalal	Non Exe.Non Ind.Director
Mrs. Gurveen Singh	Independent Director
Mr. Vinod Rao	Independent Director
Mr. Homi Adi Katgara	Independent Director
Mr. Shashank Shankar Samant	Independent Director

FAQ

What is the intrinsic value of Eureka Forbes Ltd?

Eureka Forbes Ltd's intrinsic value (as of 27 April 2025) is ₹300.91 — 39.82% lower the current market price of 500.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 9,670 Cr. market cap, FY2025-2026 high/low of ₹648/397, reserves of 4,100 Cr, and liabilities of 6,359 Cr.

What is the Market Cap of Eureka Forbes Ltd?

The Market Cap of Eureka Forbes Ltd is 9,670 Cr..

What is the current Stock Price of Eureka Forbes Ltd as on 27 April 2025?

The current stock price of Eureka Forbes Ltd as on 27 April 2025 is 500.

What is the High / Low of Eureka Forbes Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Eureka Forbes Ltd stocks is ₹648/397.

What is the Stock P/E of Eureka Forbes Ltd?

The Stock P/E of Eureka Forbes Ltd is 67.8.

What is the Book Value of Eureka Forbes Ltd?

The Book Value of Eureka Forbes Ltd is 222.

What is the Dividend Yield of Eureka Forbes Ltd?

The Dividend Yield of Eureka Forbes Ltd is 0.00 %.

What is the ROCE of Eureka Forbes Ltd?

The ROCE of Eureka Forbes Ltd is 3.46 %.

What is the ROE of Eureka Forbes Ltd?

The ROE of Eureka Forbes Ltd is 2.45 %.

What is the Face Value of Eureka Forbes Ltd?

The Face Value of Eureka Forbes Ltd is 10.0.